Plant Health Care PLC
LSE:PHC
Plant Health Care PLC
LSE:PHC
Price:
4.381 GBX
1.18%
Updated:
May 15, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
107
Current
105.6
Median
13.8
Industry
Higher
than median
Higher
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=107
Enterprise Value
/
-417.9m
EBITDA
-4.9m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| US |
|
Plant Health Care PLC
LSE:PHC
|
15m GBP | 107 | |
| US |
|
Corteva Inc
NYSE:CTVA
|
40.2B USD | 13.1 | |
| CA |
|
Nutrien Ltd
TSX:NTR
|
38.8B CAD | 6.6 | |
| CL |
|
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
|
14.2B USD | 2.5 | |
| SA |
|
SABIC Agri-Nutrients Company SJSC
SAU:2020
|
52.5B SAR | 8.9 | |
| US |
|
CF Industries Holdings Inc
NYSE:CF
|
13.7B USD | 5.6 | |
| CN |
|
Qinghai Salt Lake Industry Co Ltd
SZSE:000792
|
94.1B CNY | 9.3 | |
| US |
|
Mosaic Co
NYSE:MOS
|
9.7B USD | 7.1 | |
| RU |
|
PhosAgro PAO
MOEX:PHOR
|
849.6B RUB | 5.8 | |
| CN |
|
Shandong Hualu-Hengsheng Chemical Co Ltd
SSE:600426
|
61.3B CNY | 15 | |
| US |
|
FMC Corp
NYSE:FMC
|
8.3B USD | 18 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
1.8
2-Years Forward
EV/EBITDA
25.5
3-Years Forward
EV/EBITDA
-0.7
You don't have any saved screeners yet
